A new central scaffold for metastasis: Parsing HEF1/Cas-L/NEDD9

Cancer Research

Volumn 67, Issue 19, 2007, Pages 8975-8979

  O'Neill, Geraldine M ^a,b   Seo, Sachiko ^c   Serebriiskii, Ilya G ^d   Lessin, Stuart R ^d   Golemis, Erica A ^d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TOKYO   (Japan)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FOCAL ADHESION KINASE; GENE PRODUCT; HISTONE DEACETYLASE 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN CAS L; PROTEIN HEF1; PROTEIN NEDD9; PROTEIN P53; RAF PROTEIN; RAP1 PROTEIN; RAS PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSCRIPTION REGULATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASMS; PHOSPHOPROTEINS; UP-REGULATION;

EID: 35148825060     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1328     Document Type: Article

References (28)

1. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun 1992;185:1155-61.
2. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh GD, Golemis EA. Human Enhancer of Filamentation 1 (HEF1), a novel p130Cas-like docking protein, associates with FAK, induces pseudohyphal growth in yeast. Mol Cell Biol 1996;16:3327-37.
3. Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, Morimoto C. Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in β-1 integrin-mediated signaling in lymphocytes. J Exp Med 1996;184:1365-75.
4. Natarajan M, Stewart JE, Golemis EA, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 2006;25:1721-32.
5. Kim M, Gans JD, Nogueira C, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125:1269-81.
6. Singh MK, Cowell L, Seo S, O'Neill GM, Golemis EA. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis, and cell cycle. Cell Biochem Biophys 2007;48:54-72.
7. Seo S, Ichikawa M, Kurokawa M. Structure and Function of Cas-L and Integrin-Mediated Signaling. Critical Reviews In Immunology 2006;26:391-406.
8. O'Neill GM, Fashena SJ, Golemis EA. Integrin signaling: a new Cas(t) of characters enters the stage. Trends Cell Biol 2000;10:111-9.
9. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-24.
10. Pugacheva EN, Golemis EA. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2kin ases at the centrosome. Nat Cell Biol 2005;7:937-46.
11. Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA. Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Mol Biol Cell 2006;17:1204-17.
12. Fashena SJ, Einarson MB, O'Neill GM, Patriotis CP, Golemis EA. Dissection of HEF1-dependent functions in motility and transcriptional regulation. J Cell Sci 2002;115:99-111.
13. Cai D, Felekkis KN, Near RI, et al. The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. J Immunol 2003;170:969-78.
14. Regelmann AG, Danzl NM, Wanjalla C, Alexandropoulos K. The hematopoietic isoform of cas-hef1-associated signal transducer regulates chemokine-induced inside-out signaling and T cell trafficking. Immunity 2006;25:907-18.
15. Seo S, Asai T, Saito T, et al. Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance. J Immunol 2005;175:3492-501.
16. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12secretion. Cell 2005;121:335-48.
17. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-6.
18. Inamoto S, Iwata S, Inamoto T, et al. Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7. Oncogene 2006;26:893-904.
19. Javelaud D, Mohammad KS,McKenna CR, et al. Stable overexpression of smad7 in human melanoma cells impairs bone metastasis. Cancer Res 2007;67:2317-24.
20. Kuehn EW, Walz G, Benzing T. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res 2007;67:4537-40.
21. Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 2007;129:1351-63.
22. Martin-Rendon E, Hale SJ, Ryan D, et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007;25:1003-12.
23. Sasaki T, Iwata S, Okano HJ, et al. Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats. Possible Involvement of Nedd9 in the Differentiation of Neurons After Ischemia. Stroke 2005;36:2457-62.
24. Zheng M, McKeown-Longo PJ. Regulation of HEF1 expression and phosphorylation by TGF-β 1 and cell adhesion. J Biol Chem 2002;277:39599-608.
25. de Jong R, van Wijk A, Haataja L, Heisterkamp N, Groffen J. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl. J Biol Chem 1997;272:32649-55.
26. Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005;8:241-54.
27. Sawada Y, Tamada M, Dubin-Thaler BJ, et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 2006;127:1015-26.
28. Serebriiskii IG, Mitina O, Pugacheva EN, et al. Detection of peptides, proteins, and drugs that selectively interact with protein targets. Genome Res 2002;12:1785-91.